The United Kingdom National Bariatric Surgery Registry 2nd Report (2014)
-
Code:ISBN 978-0-9568154-8-4
The second National Bariatric Surgery Registry Report, published by Dendrite Clinical Systems and the British Obesity and Metabolic Surgery Society (BOMSS), includes over 18,000 patient records and records that the observed in-hospital mortality rate after primary surgery was 0.07% with a surgical complication rate for primary operations of 2.9%. At the time of primary surgery the average BMI was 48.8 kg m-2, which means that patients were almost twice their ideal weight with 53.9% of men and 41.4% of women recording 4 or more obesity related diseases.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


